ASMB CIK: 1426800

Assembly Biosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−133
FY22:
−94.1
FY23:
−64.6
FY24:
−45.4
FY25:
−12.1
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−93.6
FY23:
−64.2
FY24:
−45.3
FY25:
−12.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−132
FY22:
−93.1
FY23:
−61.2
FY24:
−39.8
FY25:
−6.12
(positive)
Change from FY21 to FY25
millions USD
FY21:
−130
FY22:
−93.1
FY23:
−61.2
FY24:
−40.2
FY25:
−6.12

All amounts in millions USD Data sources:SEC EDGARTwelve Data